New 13D18
New 13G50
Stated intents1
The week of 2026-04-13, 18 holders filed a new Schedule 13D and 50 a new Schedule 13G reporting 5% or more of a company, and 1 13D filing stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-14 | Third Point Private Capital Partners | Third Point LLC | 76.6% | SCHEDULE 13D |
| 2026-04-16 | Lianhe Sowell International Group Ltd | Yue Zhu | 72.45% | SCHEDULE 13D |
| 2026-04-14 | K-Tech Solutions Co Ltd | Kwok Yiu Fai | 72.29% | SCHEDULE 13D |
| 2026-04-17 | Integrated Biopharma Inc | DeSantis Damon | 41.3% | SCHEDULE 13D |
| 2026-04-15 | Suncrete, Inc. | SunTx Capital Management Corp. | 34% | SCHEDULE 13D |
| 2026-04-15 | YY Group Holding Limited | Hyperscale Data, Inc. | 29.6% | SCHEDULE 13D |
| 2026-04-15 | Apogee Acquisition Corp | Apogee Acquisition Sponsor LLC | 25.4% | SCHEDULE 13D |
| 2026-04-17 | Davion Healthcare Plc | Jack Harry Kaye | 20.64% | SCHEDULE 13D |
| 2026-04-15 | Escalade Inc | Patrick J Griffin | 20.6% | SCHEDULE 13D |
| 2026-04-16 | CalEthos, Inc. | Joel Drake Stone | 12.2% | SCHEDULE 13D |
| 2026-04-15 | Suncrete, Inc. | Randall W. Edgar | 10.3% | SCHEDULE 13D |
| 2026-04-13 | Odyssey Marine Exploration Inc | Two Seas Capital LP | 9.99% | SCHEDULE 13D |
| 2026-04-13 | SharonAI Holdings Inc. | Andrew Leece | 9.05% | SCHEDULE 13D |
| 2026-04-15 | Repay Holdings Corporation | Veradace Capital Management LLC | 8.6% | SCHEDULE 13D |
| 2026-04-15 | Suncrete, Inc. | Haymaker Sponsor IV LLC | 7.7% | SCHEDULE 13D |
| 2026-04-13 | Barinthus Biotherapeutics plc. | International Generosity Foundation Trust | 6.7% | SCHEDULE 13D |
| 2026-04-16 | VASO Corp | Jun Ma | 6% | SCHEDULE 13D |
| 2026-04-17 | Barnwell Industries Inc | JCP Investment Management, LLC | 5.1% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-13 | Eastern International Ltd. | Eastern1 Holdings Ltd. | 29.8% | SCHEDULE 13G |
| 2026-04-17 | Versamet Royalties Corp | B2Gold Corp. | 28.83% | SCHEDULE 13G |
| 2026-04-15 | Blue Water Acquisition Corp. Iv | Blue Water Acquisition IV LLC | 27.8% | SCHEDULE 13G |
| 2026-04-13 | Bleichroeder Acquisition Corp. II | Bleichroeder Sponsor 2 LLC | 25% | SCHEDULE 13G |
| 2026-04-13 | Praetorian Acquisition Corp. | Praetorian Sponsor LLC | 24.86% | SCHEDULE 13G |
| 2026-04-15 | Soren Acquisition Corp. | Soren Holdings LLC | 24.3% | SCHEDULE 13G |
| 2026-04-15 | OneIM Acquisition Corp. | OneIM Sponsor LLC | 20.3% | SCHEDULE 13G |
| 2026-04-16 | DevvStream Corp. | Focus Impact Partners, LLC | 19% | SCHEDULE 13G |
| 2026-04-14 | CoinShares PLC | Newton Russell Paul | 11.5% | SCHEDULE 13G |
| 2026-04-16 | Black Rock Coffee Bar, Inc. | Tyson Switzenberg | 11.4% | SCHEDULE 13G |
| 2026-04-17 | Methanex Corporation | Key Group Long Term Investments LP | 11.4% | SCHEDULE 13G |
| 2026-04-15 | CoinShares PLC | Howard Alan E | 10.9% | SCHEDULE 13G |
| 2026-04-16 | Knightscope, Inc. | Rose Eric James | 10.7% | SCHEDULE 13G |
| 2026-04-17 | Suncrete, Inc. | Harraden Circle Investments, LLC | 10.5% | SCHEDULE 13G |
| 2026-04-13 | Relay Therapeutics, Inc. | Perceptive Advisors LLC | 9.99% | SCHEDULE 13G |
| 2026-04-13 | PAVmed Inc. | Scopia Holdings LLC | 9.9% | SCHEDULE 13G |
| 2026-04-17 | Immunic, Inc. | Avidity Partners Management LP | 9.9% | SCHEDULE 13G |
| 2026-04-14 | Connect Biopharma Holdings Ltd | Wubin Pan | 9.6% | SCHEDULE 13G |
| 2026-04-14 | T. Rowe Price Exchange-Traded Funds, Inc. | Robert W. Baird & Co. Inc | 9.2% | SCHEDULE 13G |
| 2026-04-13 | BrilliA Inc | Taslim Podiono | 8.75% | SCHEDULE 13G |
| 2026-04-15 | PS International Group Ltd. | Chuanbiao Liao | 8.03% | SCHEDULE 13G |
| 2026-04-14 | Dynamix Corp | Kenneth Griffin | 7.9% | SCHEDULE 13G |
| 2026-04-13 | Lexeo Therapeutics, Inc. | Suvretta Capital Management, LLC | 7.7% | SCHEDULE 13G |
| 2026-04-17 | Beasley Broadcast Group Inc | Turning Rock Capital Partners, LP | 7.5% | SCHEDULE 13G |
| 2026-04-16 | America's Car-Mart Inc. | Prescott Group Capital Management, L.L.C. | 7.2% | SCHEDULE 13G |
| 2026-04-14 | Apogee Acquisition Corp | Harraden Circle Investments, LLC | 7.05% | SCHEDULE 13G |
| 2026-04-17 | Globant S.A. | Pzena Investment Management LLC | 6.9% | SCHEDULE 13G |
| 2026-04-16 | Agomab Therapeutics NV | Pontifax VI G.P. L.P. | 6.8% | SCHEDULE 13G |
| 2026-04-17 | Nektar Therapeutics | Two Seas Capital LP | 6.8% | SCHEDULE 13G |
| 2026-04-17 | Starz Entertainment Corp. | CastleKnight Master Fund LP | 6.7% | SCHEDULE 13G |
| 2026-04-17 | Corebridge Financial, Inc. | Pzena Investment Management LLC | 6% | SCHEDULE 13G |
| 2026-04-17 | Robert Half Inc. | Pzena Investment Management LLC | 5.9% | SCHEDULE 13G |
| 2026-04-17 | CNS Pharmaceuticals, Inc. | Ikarian Capital, LLC | 5.7% | SCHEDULE 13G |
| 2026-04-17 | SEMrush Holdings, Inc. | Glazer Capital, LLC | 5.59% | SCHEDULE 13G |
| 2026-04-13 | Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. | Evergreen Capital Management LLC | 5.42% | SCHEDULE 13G |
| 2026-04-15 | SharonAI Holdings Inc. | Millennium Management LLC | 5.4% | SCHEDULE 13G |
| 2026-04-15 | Zymeworks Inc. | Perceptive Advisors LLC | 5.4% | SCHEDULE 13G |
| 2026-04-16 | Skeena Resources Ltd | Key Group Long Term Investments LP | 5.3% | SCHEDULE 13G |
| 2026-04-17 | Marcus & Millichap Inc | Pzena Investment Management LLC | 5.3% | SCHEDULE 13G |
| 2026-04-14 | Mobilicom Ltd | Wexford Capital LP | 5.27% | SCHEDULE 13G |
| 2026-04-16 | New ERA Energy & Digital, Inc. | Davidson Kempner Capital Management LP | 5.22% | SCHEDULE 13G |
| 2026-04-13 | Panamera Holdings Corp | Fuller Robin R. | 5.2% | SCHEDULE 13G |
| 2026-04-14 | Codexis, Inc. | Integrated Core Strategies (US) LLC | 5.2% | SCHEDULE 13G |
| 2026-04-14 | Ocugen, Inc. | Millennium Management LLC | 5.2% | SCHEDULE 13G |
| 2026-04-14 | AllianceBernstein National Mun | Allspring Global Investments Holdings, LLC | 5.1% | SCHEDULE 13G |
| 2026-04-15 | TeraWulf Inc. | Lone Pine Capital LLC | 5.1% | SCHEDULE 13G |
| 2026-04-15 | Clearfield, Inc. | ACK Asset Management LLC | 5.1% | SCHEDULE 13G |
| 2026-04-16 | Byrna Technologies Inc. | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-04-17 | Contineum Therapeutics, Inc. | Millennium Management LLC | 5.1% | SCHEDULE 13G |
| 2026-04-16 | CytomX Therapeutics, Inc. | Point72 Asset Management, L.P. | 5% | SCHEDULE 13G |
Stated intent
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-04-13 | Catalyst Bancorp, Inc. | Stilwell Joseph intent stated | 8.6% | SCHEDULE 13D/A |
Download this data (CSV)71 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.